Thompson Alexis A.

CIK 00018518951 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001851895

Recent Transactions

16 trades

Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−4,800→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−11,200→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−1,412→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−5,600→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−3,600→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−3,308→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-06-14+908→ 3,308 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-06-14+3,600→ 3,600 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-14+5,600→ 5,600 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-06-14−908→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-03-17−2,400→ 4,800 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-03-17+2,400→ 2,400 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-06-17+908→ 908 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-17+1,412→ 1,412 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-03-17+7,200→ 7,200 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-17+11,200→ 11,200 total

Companies

Global Blood Therapeutics, Inc.
Director

Recent Filings

Address

C/O GLOBAL BLOOD THERAPEUTICS, INC. 181 OYSTER POINT BLVD.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov